Please note: The information displayed on this page might be outdated.
Nouscom AG: Nouscom is a next-generation immunotherapy company developing genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. The company has offices in Basel and Rome.
Company Participants at Spring Private Company Showcase
Marina Udier, PhD
Nouscom AG, Chief Executive Officer
Marina was an Operating Principal with Versant Ventures where she collaborated with multiple new and existing portfolio companies; her responsibilities included pre-IPO activities, full scientific and commercial diligences, and new company creation. Prior to Versant, Marina spent 6 years with Novartis Pharma in Basel in various development and business roles; as the Global Commercial Head, Near Patient Testing Unit, Marina developed the global strategy for a point of care diagnostics platform. Her experience in molecular diagnostics extends to In Vitro Diagnostics in oncology where she led development of a companion diagnostics for an AML drug candidate. She managed the Global Alzheimer’s and Parkinson’s portfolio for Novartis Neuroscience where she drove her Brand to a blockbuster status by focusing on operational implementation of global strategies. Marina spent 5 years with McKinsey & Company in Chicago, working with Fortune 500 companies on strategy and marketing projects. Marina received her B.S in Chemistry from the University of Zagreb in Croatia and her PhD in Organic Chemistry from Yale University.